|
Volumn 7, Issue SUPPL. 1, 2001, Pages
|
Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease
|
Author keywords
6 mercaptopurine; Azathioprine; CDP 571; Corticosteroids; Crohn's disease; Cyclosporine budesonide; Etanercept; Inflammatory bowel disease; Infliximab; Methotrexate; Thalidomide. 2001 crohn's colitis foundation of america, inc
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
AZATHIOPRINE;
BUDESONIDE;
CYCLOSPORIN;
GASTROINTESTINAL AGENT;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
MERCAPTOPURINE;
METHOTREXATE;
MONOCLONAL ANTIBODY;
NONSTEROID ANTIINFLAMMATORY AGENT;
THALIDOMIDE;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
TUMOR NECROSIS FACTOR RECEPTOR;
CLINICAL TRIAL;
CROHN DISEASE;
FEMALE;
HUMAN;
MALE;
REVIEW;
TREATMENT OUTCOME;
6-MERCAPTOPURINE;
ANTI-INFLAMMATORY AGENTS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, MONOCLONAL;
AZATHIOPRINE;
BUDESONIDE;
CLINICAL TRIALS;
CROHN DISEASE;
CYCLOSPORINE;
FEMALE;
GASTROINTESTINAL AGENTS;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
METHOTREXATE;
RECEPTORS, TUMOR NECROSIS FACTOR;
THALIDOMIDE;
TREATMENT OUTCOME;
|
EID: 0001879729
PISSN: 10780998
EISSN: None
Source Type: Journal
DOI: 10.1002/ibd.3780070506 Document Type: Article |
Times cited : (26)
|
References (5)
|